Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium

Background. Venous thrombosis is the most common cause of obstetric morbidity and mortality during pregnancy and puerperium. The incidence of pregnancy associated venous thrombosis varies from 1 in 1000 to 1 in 2000 deliveries. Factor V G1691A (FV Leiden), FII G20210A and MTHFR C677T mutations are t...

Full description

Saved in:
Bibliographic Details
Main Authors: Đorđević Valentina, Rakićević Ljiljana B., Spasić Miloš, Miljić Predrag, Miković Danijela, Kovač Mirjana, Radojković Dragica
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2005-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503201D.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850250489761890304
author Đorđević Valentina
Rakićević Ljiljana B.
Spasić Miloš
Miljić Predrag
Miković Danijela
Kovač Mirjana
Radojković Dragica
author_facet Đorđević Valentina
Rakićević Ljiljana B.
Spasić Miloš
Miljić Predrag
Miković Danijela
Kovač Mirjana
Radojković Dragica
author_sort Đorđević Valentina
collection DOAJ
description Background. Venous thrombosis is the most common cause of obstetric morbidity and mortality during pregnancy and puerperium. The incidence of pregnancy associated venous thrombosis varies from 1 in 1000 to 1 in 2000 deliveries. Factor V G1691A (FV Leiden), FII G20210A and MTHFR C677T mutations are the most common genetic risk factors for thromboembolism. The aim of this study was to establish the presence of these risk factors in a group of women with an episode of deep venous thrombosis during pregnancy or puerperium. Methods. The study was carried in a group of 45 women with the first episode of deep venous thrombosis during pregnancy or puerperium. The patients with antiphospholipid antibodies, antithrombin III, protein C or protein S deficiency, and autoimmune and malignant diseases were excluded from the study. FV Leiden, FII G20210A, and MTHFR C677T mutations were detected by polymerase chain reaction, followed by digestion with specific restriction enzymes. Results. Twenty heterozygous carriers of the FV Leiden mutation and one homozygous carrier were detected, which represents the frequencies of 44.4% and 2.2%, respectively. For the FII G20210A mutation, six heterozygous carriers were identified, giving the frequency of 13.3%. The MTHFR C677T mutation was observed in 31 patients (22 heterozygous and 9 homozygous carriers) which represents the frequencies of 48.9% and 20%, respectively. Conclusion. Our study suggested that the obligatory testing for FV Leiden and FII G20210A mutations was strongly recommended in women with history of venous thrombosis during pregnancy and puerperium. We found a slight effect of MTHFR 677T allele, but it should be considered in association with other risk factors.
format Article
id doaj-art-844e30ec4986455d97cbfca3dff10549
institution OA Journals
issn 0042-8450
language English
publishDate 2005-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-844e30ec4986455d97cbfca3dff105492025-08-20T01:58:11ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502005-01-0162320120510.2298/VSP0503201DFactor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperiumĐorđević ValentinaRakićević Ljiljana B.Spasić MilošMiljić PredragMiković DanijelaKovač MirjanaRadojković DragicaBackground. Venous thrombosis is the most common cause of obstetric morbidity and mortality during pregnancy and puerperium. The incidence of pregnancy associated venous thrombosis varies from 1 in 1000 to 1 in 2000 deliveries. Factor V G1691A (FV Leiden), FII G20210A and MTHFR C677T mutations are the most common genetic risk factors for thromboembolism. The aim of this study was to establish the presence of these risk factors in a group of women with an episode of deep venous thrombosis during pregnancy or puerperium. Methods. The study was carried in a group of 45 women with the first episode of deep venous thrombosis during pregnancy or puerperium. The patients with antiphospholipid antibodies, antithrombin III, protein C or protein S deficiency, and autoimmune and malignant diseases were excluded from the study. FV Leiden, FII G20210A, and MTHFR C677T mutations were detected by polymerase chain reaction, followed by digestion with specific restriction enzymes. Results. Twenty heterozygous carriers of the FV Leiden mutation and one homozygous carrier were detected, which represents the frequencies of 44.4% and 2.2%, respectively. For the FII G20210A mutation, six heterozygous carriers were identified, giving the frequency of 13.3%. The MTHFR C677T mutation was observed in 31 patients (22 heterozygous and 9 homozygous carriers) which represents the frequencies of 48.9% and 20%, respectively. Conclusion. Our study suggested that the obligatory testing for FV Leiden and FII G20210A mutations was strongly recommended in women with history of venous thrombosis during pregnancy and puerperium. We found a slight effect of MTHFR 677T allele, but it should be considered in association with other risk factors.http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503201D.pdfgenesmutationfactor Vprothrombinblood coagulation disordersthrombosispregnancypuerperiumrisk factors
spellingShingle Đorđević Valentina
Rakićević Ljiljana B.
Spasić Miloš
Miljić Predrag
Miković Danijela
Kovač Mirjana
Radojković Dragica
Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
Vojnosanitetski Pregled
genes
mutation
factor V
prothrombin
blood coagulation disorders
thrombosis
pregnancy
puerperium
risk factors
title Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
title_full Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
title_fullStr Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
title_full_unstemmed Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
title_short Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
title_sort factor v leiden fii g20210a mthfr c677t mutations as risk factors for venous thrombosis during pregnancy and puerperium
topic genes
mutation
factor V
prothrombin
blood coagulation disorders
thrombosis
pregnancy
puerperium
risk factors
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503201D.pdf
work_keys_str_mv AT đorđevicvalentina factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT rakicevicljiljanab factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT spasicmilos factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT miljicpredrag factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT mikovicdanijela factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT kovacmirjana factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium
AT radojkovicdragica factorvleidenfiig20210amthfrc677tmutationsasriskfactorsforvenousthrombosisduringpregnancyandpuerperium